Showing 121-130 of 1741 results for "".
Movement Disorders Moment: Use of 3D Motion Capture for Kinematic Analysis in Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-use-of-3d-motion-capture-for-kinematic-analysis-in-movement-disorders/32077/The emerging technology, 3D motion capture, can improve diagnosis, clinical decision-making, and clinical trial precision in movement disorders.Emerging Treatments for Tardive Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-treatments-for-tardive-syndrome/32042/Practical approaches and emerging treatments offer novel therapeutic strategies for tardive syndrome.Implantable Neuromodulation for Chronic Pain & Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/implantable-neuromodulation-for-chronic-pain-headache/31788/From spinal cord stimulation to intrathecal pumps, neuromodulation can be highly effective for chronic pain syndromes and headache disorders.Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies/32136/Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes.Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://practicalneurology.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Neuropsychologic Assessment for Neurodegeneration
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychologic-assessment-for-neurodegeneration/31532/What is the value of neuropsychologic assessment in neurodegenerative diseases?Tuberculous Radiculomyelitis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/tuberculous-radiculomyelitis/32030/A rare complication of central nervous system tuberculosisA Choreographed Approach to the Treatment of Chorea
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-choreographed-approach-to-the-treatment-of-chorea/32166/The treatment approach to chorea benefits from individualized patient considerations and multidisciplinary methodology.- Letters to the Editor: The tPA Debate Continues: “Dr. Anonymous” Respondshttps://practicalneurology.com/columns/practice-management/letters-to-the-editor-the-tpa-debate-continues-dr-anonymous-responds/31488/Ongoing Debate on tPA Use in Acute Stroke ManagementAn anonymous physician from Oklahoma responds to prior discussions on the use of tissue plasminogen activator (tPA) in acute stroke treatment, emphasizing a cautious approach grounded in ethical and practical considerations. The physician clarifies
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0708Epilepsy-pdf/31003/Complementary and Alternative Medical Therapies (CAMs) are increasingly utilized by patients with epilepsy, highlighting the necessity for healthcare professionals to be vigilant about their potential impacts. CAMs encompass a variety of treatments, including herbal medicines, dietary supplements, a